Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Wright

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120Farley Cleghorn, Jean W Pape, Mauro Schechter, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2018
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban BangladeshKristen D C Lewis, Justin R Ortiz, Mohammed Z Rahman, et al.
Lancet (London, England)|April 20, 2010
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisHarish Nair, D James Nokes, Bradford D Gessner, et al.
BMC Immunology|February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Characterization of SARS-CoV-2 Convalescent Patients' Serological Repertoire Reveals High Prevalence of Iso-RBD AntibodiesNicholas C Curtis, Seungmin Shin, Andrew P Hederman, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapyHarini Natarajan, Andrew R Crowley, Savannah E Butler, et al.
Mbio|April 21, 2021
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent PlasmaHarini Natarajan, Andrew R Crowley, Savannah E Butler, et al.
The Journal of Infectious Diseases|January 28, 2004
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months oldRobert B Belshe, Frances K Newman, Theodore F Tsai, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120Farley Cleghorn, Jean W Pape, Mauro Schechter, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2018
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban BangladeshKristen D C Lewis, Justin R Ortiz, Mohammed Z Rahman, et al.
Lancet (London, England)|April 20, 2010
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisHarish Nair, D James Nokes, Bradford D Gessner, et al.
BMC Immunology|February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Characterization of SARS-CoV-2 Convalescent Patients' Serological Repertoire Reveals High Prevalence of Iso-RBD AntibodiesNicholas C Curtis, Seungmin Shin, Andrew P Hederman, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapyHarini Natarajan, Andrew R Crowley, Savannah E Butler, et al.
Mbio|April 21, 2021
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent PlasmaHarini Natarajan, Andrew R Crowley, Savannah E Butler, et al.
The Journal of Infectious Diseases|January 28, 2004
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months oldRobert B Belshe, Frances K Newman, Theodore F Tsai, et al.
Pageof 16